Page 7 - CTPA Annual Report 2011

Basic HTML Version

4.
Executive Summary
View from Dr Chris Flower,
CTPA Director-General
2011 saw several key issues remain
with us as work continued on
developing specific guidance for
members on the new EC Cosmetics
Regulation. This involved in particular
the database developed by the
European Commission that will
form the central notification portal
for all cosmetic products marketed in Europe and where right
of access and confidentiality of information were important
issues. Other aspects covered the revised format for the
cosmetic product safety report and the need for notification
of nanomaterials. However, a major issue throughout the
year was managing the implementation of the testing and
marketing bans due to come into effect in 2013.
The European Commission, under the Cosmetics Directive,
had to assess the scientific progress towards the development
of alternatives to animal testing and, if insufficient to enable
animal testing to be replaced, to make a legislative proposal
during 2011. The proposal required an assessment of the
impact of the ban on costs to industry. Providing industry’s
input was a priority during 2011; it demonstrated the potential
for significant adverse effects on the innovative capacity of the
European cosmetics industry and its competitive advantage
in a global market. Owing to the complexity of this issue,
the European Commission was unable to come forward with
a legislative proposal during 2011.
Animal testing is but one area where CTPA has worked
hard to ensure clear information is readily available to
ensure misunderstandings are corrected. It is important to
know unequivocally that the testing on animals of cosmetic
products has long been prohibited under European law.
The remaining discussions are largely around the technicalities,
such as managing apparent conflicts with other legislation
where animal-testing of chemicals may still be necessary.
Communications planning has also been actively invoked in
correcting the continued misinformation regarding so-called
dangerous ingredients. Here we have seen fewer concerns of
late and greater appreciation of the facts. But we must not rest
on our laurels, because there are always people seeking ever
more remote risks with which to challenge us.
In issues such as the use of animals in safety testing,
the innovative use of nanomaterials and the question of risk
to health from various chemicals we use as ingredients or
which might be found as traces in products, the cosmetics
industry may not have been the major player but was
certainly at the forefront of explaining its position clearly
and pro-actively throughout the year.
2011 saw the emergence of a new question where again the
cosmetics industry may find itself needing to be very clear in
its position as a responsible player – that of body confidence.
The problem of low self-esteem is a complex social one
where many factors interact: the simplistic view that seeing
glamorous images leads to eating disorders is almost certainly
incorrect. However, as a responsible industry, we must become
involved in the debate, to dissect its many factors and ensure
we are not, however inadvertently, contributing to an
avoidable problem. But this is a long-term objective and it
must not be highjacked to provide an illusionary quick win
that ultimately betrays the very people in need of help.
Once again, I would like to thank the members for their
continued support throughout 2011 and particularly those
individuals who contribute through participation in the
many committees, working groups and task forces both
here and in Brussels. Without that support, CTPA and the
Secretariat could not continue to be the authoritative public
voice of a vibrant and responsible UK industry, trusted to
act for the consumer.
Executive Comment
The CTPA has worked with members through the year on
issues that are key to understanding the way consumers
engage with their brands. Trust in the science behind cosmetics
and understanding the industry’s communications is not a
given and a responsible industry must ensure that it responds
to the needs of its consumers and the view of the regulators.
With products that range from daily essentials to those that
impart a sense of well-being, it is incumbent on our industry
to deliver only safe, effective and sustainable products.
Dr Ged O’Shea
Anand Rangaswamy
John Harold